![David Stamler](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Stamler
Chief Executive Officer at
ALTERITY THERAPEUTICS
Net worth: 12 344 $ as of 30/05/2026
Profile
David A. Stamler is Chief Executive Officer, MD & Director at Alterity Therapeutics Ltd. since 2025.
Former roles include Vice President-Clinical Development & Therapeutic at Teva Pharmaceutical Industries Ltd. from 2015 to 2017, Chief Medical Officer at Auspex Pharmaceuticals, Inc. from 2011 to 2015, Chief Medical Officer & Senior Vice President at XenoPort, Inc. from 2008 to 2010, Chief Scientific Officer & Head-Drug Development at Prestwick Pharmaceuticals, Inc. from 2005 to 2008, Senior Global Project Leader-CNS Diseases at Fujisawa Pharmaceutical Co., Ltd. from 2003 to 2005, Vice President-Research & Development at Fujisawa Healthcare, Inc. from 2003 to 2005, Vice President- Clinical Research Center at Astellas Research Institute of America LLC from 2000 to 2003, Director-Clinical Research at Abbott Laboratories from 1993 to 1997.
Education includes undergraduate studies at The University of Chicago and a doctorate from Pritzker School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 14/04/2026 | 1,904,862 ( 0.02% ) | 12 344 $ | 30/05/2026 |
David Stamler active positions
| Companies | Position | Start |
|---|---|---|
| ALTERITY THERAPEUTICS | Chief Executive Officer | 06/01/2021 |
Former positions of David Stamler
| Companies | Position | End |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 31/12/2016 |
| AUSPEX PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 04/05/2015 |
| XENOPORT, INC. | Chief Tech/Sci/R&D Officer | 18/11/2010 |
Prestwick Pharmaceuticals, Inc.
 Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Chief Tech/Sci/R&D Officer | 31/12/2007 |
Fujisawa Pharmaceutical Co., Ltd.
 Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Corporate Officer/Principal | 31/12/2004 |
Training of David Stamler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals and medical products | Health Technology |
Prestwick Pharmaceuticals, Inc.
Prestwick Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for diseases related to the central nervous system | Health Technology |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fujisawa Healthcare, Inc. | |
Astellas Research Institute of America LLC
 Astellas Research Institute of America LLC Miscellaneous Commercial ServicesCommercial Services Operates as a pharmaceutical research & development company | Commercial Services |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- David Stamler
